137 related articles for article (PubMed ID: 8402651)
1. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas.
Kobrin MS; Yamanaka Y; Friess H; Lopez ME; Korc M
Cancer Res; 1993 Oct; 53(20):4741-4. PubMed ID: 8402651
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions.
Kornmann M; Ishiwata T; Beger HG; Korc M
Oncogene; 1997 Sep; 15(12):1417-24. PubMed ID: 9333017
[TBL] [Abstract][Full Text] [Related]
3. Expression of the fibroblast growth factor receptor-1 in human normal tissues and tumors determined by a new monoclonal antibody.
Morikawa Y; Ishihara Y; Tohya K; Kakudo K; Seo MK; Matsuura N
Arch Pathol Lab Med; 1996 May; 120(5):490-6. PubMed ID: 8639054
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
Yamanaka Y; Friess H; Buchler M; Beger HG; Uchida E; Onda M; Kobrin MS; Korc M
Cancer Res; 1993 Nov; 53(21):5289-96. PubMed ID: 7693336
[TBL] [Abstract][Full Text] [Related]
5. Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells.
Liu Z; Ishiwata T; Zhou S; Maier S; Henne-Bruns D; Korc M; Bachem M; Kornmann M
Pancreas; 2007 Aug; 35(2):147-57. PubMed ID: 17632321
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of keratinocyte growth factor in human pancreatic cancer.
Siddiqi I; Funatomi H; Kobrin MS; Friess H; Büchler MW; Korc M
Biochem Biophys Res Commun; 1995 Oct; 215(1):309-15. PubMed ID: 7575607
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF
Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biology of pancreatic cancer: overexpression of fibroblast growth factors].
Friess H; Korc M; Büchler MW
Chirurg; 1994 Jul; 65(7):604-10. PubMed ID: 7523040
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of fibroblast growth factor receptor 1 expression in human glioblastoma cell contributes to the cell growth suppression].
Yamada SM; Yamaguchi F; Morrison RS; Takahashi H; Teramoto A
No To Shinkei; 1998 Dec; 50(12):1101-5. PubMed ID: 9989355
[TBL] [Abstract][Full Text] [Related]
11. Induction and expression of amphiregulin in human pancreatic cancer.
Ebert M; Yokoyama M; Kobrin MS; Friess H; Lopez ME; Büchler MW; Johnson GR; Korc M
Cancer Res; 1994 Aug; 54(15):3959-62. PubMed ID: 8033121
[TBL] [Abstract][Full Text] [Related]
12. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma.
Ueki T; Koji T; Tamiya S; Nakane PK; Tsuneyoshi M
J Pathol; 1995 Dec; 177(4):353-61. PubMed ID: 8568589
[TBL] [Abstract][Full Text] [Related]
13. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.
Friess H; Yamanaka Y; Büchler M; Berger HG; Kobrin MS; Baldwin RL; Korc M
Cancer Res; 1993 Jun; 53(12):2704-7. PubMed ID: 8389240
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.
Kaipainen A; Vlaykova T; Hatva E; Böhling T; Jekunen A; Pyrhönen S; Alitalo K
Cancer Res; 1994 Dec; 54(24):6571-7. PubMed ID: 7987857
[TBL] [Abstract][Full Text] [Related]
16. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.
Kleeff J; Fukahi K; Lopez ME; Friess H; Büchler MW; Sosnowski BA; Korc M
Cancer Gene Ther; 2002 Jun; 9(6):522-32. PubMed ID: 12032663
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of fibroblast growth factor 8 in human breast cancer.
Marsh SK; Bansal GS; Zammit C; Barnard R; Coope R; Roberts-Clarke D; Gomm JJ; Coombes RC; Johnston CL
Oncogene; 1999 Jan; 18(4):1053-60. PubMed ID: 10023681
[TBL] [Abstract][Full Text] [Related]
18. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
19. IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells.
Kornmann M; Ishiwata T; Matsuda K; Lopez ME; Fukahi K; Asano G; Beger HG; Korc M
Gastroenterology; 2002 Jul; 123(1):301-13. PubMed ID: 12105858
[TBL] [Abstract][Full Text] [Related]
20. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer.
Ishiwata T; Friess H; Büchler MW; Lopez ME; Korc M
Am J Pathol; 1998 Jul; 153(1):213-22. PubMed ID: 9665482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
